Skip to content

Predictive Value of Risk Scores in Acute Coronary Syndrome

Role of TIMI, PURSUIT and GRACE Risk Scores in Predicting LV Remodeling in Patients With Acute Coronary Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03549481
Enrollment
200
Registered
2018-06-08
Start date
2018-07-09
Completion date
2019-01-31
Last updated
2018-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome, Left Ventricle Remodeling, Risk Scores

Keywords

risk score, acute coronary syndrome, left ventricular remodelng

Brief summary

role of different risk scores in acute coronary syndrome to predict left ventricular remodeling

Detailed description

patients with acute coronary syndrome (STEMI, NSTEMI, UA) will be included and different risk scores will be calculated for each patient. after that in-hospital and short-term outcome beside left ventricular systolic and diastolic functions (at admission and 3m later) will be assessed to be correlated with different risk scores to determine which score system was able to predict left ventricular remodeling and what was the cut off value, sensitivity, and specificity of the score

Interventions

None listed

Sponsors

shaimaa Mostafa
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with acute coronary syndrome

Exclusion criteria

* previous acute coronary syndrome previous PCI or CABG chronic renal disease decompensated liver disease patient refusal to participate patients dropped during follow up

Design outcomes

Primary

MeasureTime frameDescription
left ventricular remodeling3 monthsend diastolic volume, end systolic volume, ejection fraction
in hospital and short term outcme3 monthsre-infarction, death, arrhythmia

Countries

Egypt

Contacts

Primary Contactshaimaa A Mostafa, MD
shaimaamustafa2011@gmail.com01229122843

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026